Eli Lilly looks beyond GLP-1s with a $3 billion cancer buy
Culture Index
Score Breakdown
Relevance
9/25
Freshness
25/25
Authority
18/20
Brand Signal
5/15
Depth
2/15
5-Axis Cultural Radar
Eli Lilly announced it will acquire Kelonia Therapeutics for $3.25 billion upfront to expand its oncology and genetic medicines pipeline
